 Innovation in the United States Health-Care System’s Organization and DeliveryMichael J. DiStefano,
So-Yeon Kang,
Mariana P. Socal and
Gerard Anderson
SPP Research Papers, 2022, vol. 15, issue 2 Abstract: The COVID-19 pandemic has had a galvanizing effect on policy-makers in the U.S. who are trying and testing innovations in delivering government-insured health care that Canada would be wise to take note of and learn from. As in Canada, the federal government in the U.S. is limited in how directly it can influence health-care delivery, even within programs such as Medicare and Medicaid that receive federal funding. However, it has used its significant funding power to offer states incentives to promote federal priorities. As a result, dozens of states have expanded eligibility and benefits in line with federal priorities in exchange for additional funding. The U.S. government has also encouraged states to experiment with innovative delivery or financing approaches within Medicaid by offering temporary, extendable waivers that exempt novel concepts from meeting all Medicaid requirements. This has allowed states to try new programs that target the expansion of benefits coverage. One waiver-based program, for example, allows elderly individuals to employ friends and relatives as home caregivers as an alternative to institutionalization. Digital-health initiatives have also been accelerated in the U.S. during the pandemic, including loosening restrictions to allow telehealth visits and “hospital-at-home†programs, which allow acutecare and post-acute care patients to convalesce in their own residences through remote monitoring and drug delivery. Recent payment reforms in the U.S., meanwhile, include allowing health-care providers to voluntarily band together to share medical and financial responsibility for providing quality, co-ordinated care with lower costs, resulting in notable savings. Episode-based, bundled payments for complete courses of therapy for certain conditions have lowered some costs with equal or better quality of care. Other promising payment-reform initiatives involve managed care programs with private sector participation in care and insurance offering bundles of benefits not provided by traditional government coverage. The health-care challenges experienced during the pandemic have also prompted the U.S. government to take a more active role in promoting more resilient supply chains for drugs and medical equipment, to reduce dependence on offshore manufacturers and introduce more transparency into the drug supply chain. It is also providing funds for training grants and student-loan repayment relief for health-care workers, to help ensure there are enough professionals being trained for the health-care workforce now and into the future. These efforts demonstrate how health policy-makers in the U.S., in light of the COVID-19 pandemic, are driven by innovation in navigating the trade-offs between delivering quality care, expanding care, controlling costs, and allowing for regional autonomy. These considerations are not unlike those faced by Canadian policy-makers, who can learn from American innovations to help Canada emerge from the pandemic with a stronger health-care system. Date: 2022 Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:clh:resear:v:15:y:2022:i:2 Access Statistics for this article More articles in SPP Research Papers from The School of Public Policy, University of Calgary Contact information at EDIRC. |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.